Are insiders buying or selling Hemab Therapeutics Holdings, Inc. stock?

Based on the last 50 SEC Form 4 filings, Hemab Therapeutics Holdings, Inc. insiders made 14 open-market purchases and 0 open-market sales.

Where can I see Hemab Therapeutics Holdings, Inc. insider trading activity?

SEC Form 4 filings for Hemab Therapeutics Holdings, Inc. (COAG) are publicly available on EDGAR and aggregated at form4api.com/companies/COAG.

// company-profile

Name: Hemab Therapeutics Holdings, Inc. Insider Trading Data
Creator: Form4API
License: https://www.sec.gov/privacy.htm

COAGExchange: NasdaqSector: Biological Products, (No Diagnostic Substances)Inc.: DEFilings: 8Insiders: 10

// activity-summary

Recent insider activity is bullish. Over the last 30 days, 10 insiders purchased shares (net $3.2M). Buying was led by RA CAPITAL MANAGEMENT, L.P..

// 90-day insight

Over the last 90 days, Hemab Therapeutics Holdings, Inc. insiders bought $53.8M across 16 transactions with no open-market sales.

Most active insider: RA CAPITAL MANAGEMENT, L.P. with 23 transactions totaling $53.8M.
Largest single purchase: $45.7M by RA CAPITAL MANAGEMENT, L.P. on May 4, 2026.

Activity skews bullish — buys outpace sales.

Sourced from SEC EDGAR Form 4 filings. Updated hourly.

Date	Insider	Company	Type	Shares	Price	Value	1d	1w	1m	3m	6m
May 20, 2026	RA CAPITAL MANAGEMENT, L.P.	COAG	Purchase	996	$24.94	$25K	—	—	—	—	—
May 19, 2026	RA CAPITAL MANAGEMENT, L.P.	COAG	Purchase	3,802	$24.97	$95K	—	—	—	—	—
May 12, 2026	RA CAPITAL MANAGEMENT, L.P.	COAG	Purchase	6,387	$24.90	$159K	—	—	—	—	—
May 11, 2026	RA CAPITAL MANAGEMENT, L.P.	COAG	Purchase	14,149	$24.47	$346K	—	—	—	—	—
May 11, 2026	RA CAPITAL MANAGEMENT, L.P.	COAG	Purchase	25,720	$25.00	$643K	—	—	—	—	—

32 more transactions hidden

Free account · No credit card required

Building something? Get API access →

Browse insider trading activity for other actively-filed companies.